ATAylin Tahmasebi

Aylin Tahmasebi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aylin Tahmasebi has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of simulated transient elastography sample volumes and global measurements on MRE and MRI-PDFF in patients with suspected MASLD

    by Tania Siu Xiao, Aylin Tahmasebi, Seyedeh Mohaddeseh Khatami, Cristina M. Kuon Yeng Escalante, Amr Mohammed, Mostafa Alnoury, Flavius F. Guglielmo, John R. Eisenbrey, Jesse Civan


  • Open Access

    Feasibility of Contrast-Enhanced Ultrasound Fusion With Pretreatment MR/CT for Recurrence Detection in Renal Cell Carcinoma Patients During Post-Ablation Surveillance

    by Aylin Tahmasebi, Tania Siu Xiao, Corinne E. Wessner, Cristina M. Kuon Yeng Escalante, Andrej Lyshchik, Flemming Forsberg, Ji-Bin Liu, Christopher G. Roth, Shuchi K. Rodgers, Leann M. Kania, et al.


  • Open Access

    Combining CEUS and CT/MRI LI-RADS major imaging features: diagnostic accuracy for classification of indeterminate liver observations in patients at risk for HCC

    by Tania Siu Xiao, Cristina Mariuxi Kuon Yeng Escalante, Aylin Tahmasebi, Yuko Kono, Fabio Piscaglia, Stephanie R. Wilson, Alexandra Medellin-Kowalewski, Shuchi K. Rodgers, Virginia Planz, Aya Kamaya, et al.

    Purpose: To determine the diagnostic accuracy of combining CEUS and CT/MRI LI-RADS major imaging features for the improved categorization of liver observations indeterminate on both CT/MRI and CEUS. Materials and methods: A retrospective analysis using a database from a prospective study conducted at 11 centers in North America and Europe from 2018 to 2022 included a total of 109 participants at risk for HCC who had liver observations with indeterminate characterization (LR3, LR-4, and LR-M) on both CEUS and CT/MRI. The individual CEUS and CT/MRI LI-RADS major features were extracted from the original study and analyzed in various combinations. Reference standards included biopsy, explant histology, and follow-up CT/MRI. The diagnostic performance of the combinations of LI-RADS major features for definitive diagnosis of HCC was calculated. A reverse, stepwise logistical regression sub-analysis was also performed. Results: This study included 114 observations indeterminate on both CT/MRI and CEUS. These observations were categorized as LR-3 (n = 37), LR-4 (n = 41), and LR-M (n = 36) on CT/MRI and LR-3 (n = 48), LR-4 (n = 36), LR-M (n = 29), and LR-TIV (n = 1) on CEUS. Of them, 43.0% (49/114) were confirmed as HCC, 37.3% (43/114) non-malignant, and 19.3% (22/114) non-hepatocellular malignancies. The highest diagnostic accuracy among the combinations of imaging features was achieved in CT/MRI LR-3 observations, where the combination of CEUS arterial phase hyper-enhancement (APHE) + CT/MRI APHE had 96.7% specificity, 75.0% positive predictive value (PPV), and 86.5% accuracy for HCC. Conclusion: The combination of LI-RADS major features on CT/MRI and CEUS showed higher specificity, PPV, and accuracy compared to individual modalities' assessments, particularly for CT/MRI LR-3 observations.


  • Ultrasound‐Based Machine Learning Approach for Detection of Nonalcoholic Fatty Liver Disease

    by Aylin Tahmasebi, Shuo Wang, Corinne E. Wessner, Trang Vu, Ji‐Bin Liu, Flemming Forsberg, Jesse Civan, Flavius F. Guglielmo, John R. Eisenbrey

    Objectives: Current diagnosis of nonalcoholic fatty liver disease (NAFLD) relies on biopsy or MR‐based fat quantification. This prospective study explored the use of ultrasound with artificial intelligence for the detection of NAFLD.Methods: One hundred and twenty subjects with clinical suspicion of NAFLD and 10 healthy volunteers consented to participate in this institutional review board‐approved study. Subjects were categorized as NAFLD and non‐NAFLD according to MR proton density fat fraction (PDFF) findings. Ultrasound images from 10 different locations in the right and left hepatic lobes were collected following a standard protocol. MRI‐based liver fat quantification was used as the reference standard with >6.4% indicative of NAFLD. A supervised machine learning model was developed for assessment of NAFLD. To validate model performance, a balanced testing dataset of 24 subjects was used. Sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy with 95% confidence interval were calculated.Results: A total of 1119 images from 106 participants was used for model development. The internal evaluation achieved an average precision of 0.941, recall of 88.2%, and precision of 89.0%. In the testing set AutoML achieved a sensitivity of 72.2% (63.1%–80.1%), specificity of 94.6% (88.7%–98.0%), positive predictive value (PPV) of 93.1% (86.0%–96.7%), negative predictive value of 77.3% (71.6%–82.1%), and accuracy of 83.4% (77.9%–88.0%). The average agreement for an individual subject was 92%.Conclusions: An ultrasound‐based machine learning model for identification of NAFLD showed high specificity and PPV in this prospective trial. This approach may in the future be used as an inexpensive and noninvasive screening tool for identifying NAFLD in high‐risk patients.


  • Assessment of Axillary Lymph Nodes for Metastasis on Ultrasound Using Artificial Intelligence

    by Aylin Tahmasebi, Enze Qu, Alexander Sevrukov, Ji-Bin Liu, Shuo Wang, Andrej Lyshchik, Joshua Yu, John R. Eisenbrey

    The purpose of this study was to evaluate an artificial intelligence (AI) system for the classification of axillary lymph nodes on ultrasound compared to radiologists. Ultrasound images of 317 axillary lymph nodes from patients referred for ultrasound guided fine needle aspiration or core needle biopsy and corresponding pathology findings were collected. Lymph nodes were classified into benign and malignant groups with histopathological result serving as the reference. Google Cloud AutoML Vision (Mountain View, CA) was used for AI image classification. Three experienced radiologists also classified the images and gave a level of suspicion score (1–5). To test the accuracy of AI, an external testing dataset of 64 images from 64 independent patients was evaluated by three AI models and the three readers. The diagnostic performance of AI and the humans were then quantified using receiver operating characteristics curves. In the complete set of 317 images, AutoML achieved a sensitivity of 77.1%, positive predictive value (PPV) of 77.1%, and an area under the precision recall curve of 0.78, while the three radiologists showed a sensitivity of 87.8% ± 8.5%, specificity of 50.3% ± 16.4%, PPV of 61.1% ± 5.4%, negative predictive value (NPV) of 84.1% ± 6.6%, and accuracy of 67.7% ± 5.7%. In the three external independent test sets, AI and human readers achieved sensitivity of 74.0% ± 0.14% versus 89.9% ± 0.06% (p = .25), specificity of 64.4% ± 0.11% versus 50.1 ± 0.20% (p = .22), PPV of 68.3% ± 0.04% versus 65.4 ± 0.07% (p = .50), NPV of 72.6% ± 0.11% versus 82.1% ± 0.08% (p = .33), and accuracy of 69.5% ± 0.06% versus 70.1% ± 0.07% (p = .90), respectively. These preliminary results indicate AI has comparable performance to trained radiologists and could be used to predict the presence of metastasis in ultrasound images of axillary lymph nodes.


  • Transgluteal ultrasonography in spica cast in postreduction assessment of developmental dysplasia of the hip

    by Mehrzad Mehdizadeh, Mehrshad Dehnavi, Aylin Tahmasebi, Seyed Amir Mahlisha Kazemi Shishvan, Nasir Babakhan Kondori, Razieh Shahnazari

    The position of the femoral head in spica cast after the reduction of developmental dysplasia of the hip (DDH) should be examined and followed up closely and regularly. The study aimed to use the transgluteal ultrasonography approach for this purpose and compare its accuracy with the results of CT scan, which is the most commonly used modality.